Article
Nesfatin-1 regulates the phenotype transition of cavernous smooth muscle cells by activating PI3K/AKT/mTOR signaling pathway to improve diabetic erectile dysfunction.
PloS one - 1 Jan 2024
Chen Keming, Huang Bincheng, Feng Jiajing, Hu Zhengxing, Fan Shuzhe, Ren Shuai, Tian Haifu, Abdulkarem M M Al-Qaisi Mohammed, Wang Xuehao, Tuo Yunshang, Liang Xiaoxia, Xie Haibo, He Rui, Li Guangyong
Abstract excerpt
OBJECTIVE: This study aims to explore the impact of Nesfatin-1 on type 2 diabetic erectile dysfunction (T2DMED) and its underlying mechanism in regulating the phenotypic switching of corpus cavernosum smooth muscle cells (CCSMCs). METHODS: Twenty-four 4-week-old male C57 wild-type mice were randomly assigned to the control group, model group, and Nesfatin-1 treatment group. Monitoring included body weight, blood...
Topics
Join the communities discussing this publication.
